USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Growth Opportunities in Global Biosimilars Market, Forecast to 2028
Increasing Access, Adoption, and Awareness are the Key to Future Growth Potential of Biosimilars
26-Sep-2023
Global
Market Research
$4,950.00
Special Price $4,455.00 save 10 %
Biosimilar acceptance and use are increasing as patients and healthcare providers improve their understanding and awareness of therapeutic agents driven by biosimilar manufacturers and regulators. As the availability of information and practical data supporting the safety and effectiveness of biosimilars increases, both patients and healthcare professionals are developing a greater level of confidence in these medications. It is imperative for pharmaceutical companies to delicately navigate the intricate balance between safeguarding their biologic products and cultivating an environment conducive to the presence of biosimilars, which inevitably contribute to a thriving competitive milieu.
This study presents overall market and segment-wise revenue forecasts for the global biosimilars market. It highlights key growth opportunities for biosimilar market participants based on the trends, evolution of business models, and strategic imperatives for various stakeholders. It identifies the greatest revenue-generating therapeutic areas and product types. The elements affecting regional biosimilar uptake and biosimilar market entrance have been clearly stated. In addition, this report covers complicated factors, including reimbursement and payer landscape, biosimilar price trends, and biosimilar sales trends that will affect biosimilar penetration. The study discusses regional biosimilar discrepancies as well as industry issues, including physician adoption and patent litigations. This report identifies key growth opportunities to increase biosimilar uptake and innovations and compete for newer therapy areas, such as neurology and oncology.
Author: Surbhi Gupta
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Biosimilars Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Market Segmentation
Key Regional Competitors in the Biosimilars Market
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Growth Restraints (continued)
Growth Restraints (continued)
Highlights—Biosimilars Regional Dynamics
Growth Opportunities—Biosimilars Market
Strategies to Boost Biosimilars Development and Adoption
Biopharma Taking Lead to Boost Adoption of Biosimilars—Sandoz
North America Competitive Benchmarking—Key Countries
Market Snapshot—US Biosimilar Market
Biosimilars Approved in the US
The US Healthcare Financial and Distribution Pathways
Business Model Transformation due to the Next Wave of Biosimilars
Evolving Roles of PBM Formularies to Boost Biosimilar Accessibility
Evolving US Biosimilar Regulatory Landscape
US Insulin Biosimilar Market Set for Major Reset in Response to IRA
Dual Pricing Strategy in the US
US Oncology
US Oncology Supportive Care
US Immunology and Ophthalmology
Europe Competitive Benchmarking—Key Countries
Market Snapshot—Europe Biosimilars Market
Biosimilars Approved in Europe
Biosimilars Approved in Europe (continued)
Swift and Rapid Adoption of Biosimilar—Denmark Success Story
Incentives Driving Adoption of Biosimilars
APAC and MEA Competitive Benchmarking—Key Countries
Market Snapshot—Key APAC and MEA Biosimilar Market
Intensifying Focus of Asian Biopharma and CDMO on the Global Market
Key Growth Metrics
Forecast Assumptions and Considerations—Biosimilars Market
Revenue Forecast—Global Biosimilars Market
Revenue Forecast Analysis—Global Biosimilars Market
Revenue Forecast by Product Type
Revenue Forecast Analysis by Product Type
Revenue Forecast by Therapeutic Area
New and Upcoming Key Biologics Patent Expiration
Revenue Forecast Analysis—Oncology
Revenue Forecast Analysis—Musculoskeletal and Immunology
Revenue Forecast Analysis—Endocrinology and Ophthalmology
Competitive Environment
Revenue share
Revenue Share Analysis
Growth Opportunity 1: RWE Solutions
Growth Opportunity 1: RWE Solutions (continued)
Growth Opportunity 2: Neurology Biosimilars
Growth Opportunity 2: Neurology Biosimilars (continued)
Growth Opportunity 3: Focus on the Middle East and Africa
Growth Opportunity 3: Focus on the Middle East and Africa (continued)
Growth Opportunity 4: Leveraging AI, PD, and Omics Biomarkers
Growth Opportunity 4: Leveraging AI, PD, and Omics Biomarkers (continued)
Growth Opportunity 5: Alternative Formulation Methodology for mAb Biosimilars
Growth Opportunity 5: Alternative Formulation Methodology for mAb Biosimilars (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Surbhi Gupta |
| Industries | Chemicals and Materials |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Biosimilars In Healthcare |
| Keyword 2 | Biosimilar Market Outlook |
| Keyword 3 | Biopharma Growth Opportunities |
| Podcast | No |
| Predecessor | MF9D-01-00-00-00 |
| WIP Number | PF0F-01-00-00-00 |